BioVersys AG (SWX: BIOV)
Health Care · Pharmaceuticals · CH
CHF26.50
-1.85% today · -5.6% 1Y
BioVersys AG (SWX: BIOV) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $190.96M.
Over the last twelve months the share price has lost 5.6%, trading between 21.20 and 30.70.
Tweenvest scores BioVersys AG across four factors: quality 49/100, value 46/100. Its strongest factor is quality.
BIOV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $190.96M
- Revenue (TTM)
- $5.72M
- P/E
- —
- EPS
- -4.51
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- CHF30.70
- 52-week low
- CHF21.20
- Avg volume (3M)
- —
- Shares outstanding
- 5.87M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Humedix Co., Ltd.KOSDAQ: A200670 | $196.94M | ₩25,700.00 | +5.98% |
| Ha Tay Pharmaceutical JSCHNX: DHT | $195.20M | ₫56,000.00 | +2.75% |
| Beacon Pharmaceuticals PLCDSE: BEACONPHAR | $192.58M | Tk102.60 | -0.39% |
| NervGen Pharma Corp.NasdaqCM: NGEN | $191.39M | $1.78 | -8.25% |
| NGL Fine-Chem LimitedBSE: 524774 | $187.72M | Rs2,925.50 | +0.38% |
| Oramed Pharmaceuticals Inc.NasdaqCM: ORMP | $186.77M | $4.20 | -6.46% |
| Journey Medical CorporationNasdaqCM: DERM | $186.56M | $5.95 | -9.98% |
| Orient Pharma Co., Ltd.TPEX: 4166 | $186.16M | NT$24.40 | +1.67% |
Figures last refreshed Oct 4, 2026.